BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17714418)

  • 21. Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers.
    Rayment R; Kooij TW; Zhang W; Siebold C; Murphy MF; Allen D; Willcox N; Roberts DJ
    J Immunol; 2009 Jul; 183(1):677-86. PubMed ID: 19535639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of alloimmune neonatal thrombocytopenia.
    Blanchette VS; Johnson J; Rand M
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):365-90. PubMed ID: 11030040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe fetomaternal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-1a in a mother with a rare and silenced ITGB3*0101 (GPIIIa) allele.
    Smith GA; Rankin A; Riddle C; Cheetham-Wilkinson C; Ranasinghe E; Ouwehand WH; Watkins NA
    Vox Sang; 2007 Nov; 93(4):325-30. PubMed ID: 18070277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia.
    Johnsen GM; Størvold GL; Drabbels JJM; Haasnoot GW; Eikmans M; Spruyt-Gerritse MJ; Alnæs-Katjavivi P; Scherjon SA; Redman CWG; Claas FHJ; Staff AC
    J Reprod Immunol; 2018 Sep; 129():23-29. PubMed ID: 30055414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - New insights from a large prospective screening study in Poland.
    Coucheron T; Uhrynowska M; Guz K; Orzińska A; Debska M; Gierszon A; Ahlen MT; Bertelsen EL; Berge G; Husebekk A; Brojer E; Tiller H
    J Reprod Immunol; 2023 Dec; 160():104168. PubMed ID: 37992463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.
    Ahlen MT; Husebekk A; Killie MK; Skogen B; Stuge TB
    Blood; 2009 Apr; 113(16):3838-44. PubMed ID: 19136661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia.
    Bertrand G; Martageix C; Jallu V; Vitry F; Kaplan C
    J Thromb Haemost; 2006 Mar; 4(3):628-37. PubMed ID: 16460445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
    Boehlen F; Kaplan C; de Moerloose P
    Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia.
    Ghevaert C; Campbell K; Walton J; Smith GA; Allen D; Williamson LM; Ouwehand WH; Ranasinghe E
    Transfusion; 2007 May; 47(5):901-10. PubMed ID: 17465957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
    Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions.
    Murphy MF; Metcalfe P; Waters AH; Ord J; Hambley H; Nicolaides K
    Blood; 1993 Apr; 81(8):2174-9. PubMed ID: 8471776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells.
    Anani Sarab G; Moss M; Barker RN; Urbaniak SJ
    Blood; 2009 Aug; 114(9):1954-7. PubMed ID: 19494351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study.
    Doughty HA; Murphy MF; Metcalfe P; Waters AH
    Br J Haematol; 1995 Jun; 90(2):321-5. PubMed ID: 7794750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R
    Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a.
    Turner ML; Bessos H; Fagge T; Harkness M; Rentoul F; Seymour J; Wilson D; Gray I; Ahya R; Cairns J; Urbaniak S
    Transfusion; 2005 Dec; 45(12):1945-56. PubMed ID: 16371049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia.
    Warwick RM; Vaughan J; Murray N; Lubenko A; Roberts I
    Br J Haematol; 1994 Dec; 88(4):874-7. PubMed ID: 7819112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
    Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
    Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.